Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

N-alkylpiperidine carbamates as potential anti-Alzheimer’s agents
Urban Košak, Nika Strašek, Damijan Knez, et al.
European Journal of Medicinal Chemistry (2020) Vol. 197, pp. 112282-112282
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress
Zhipei Sang, Keren Wang, Jianghong Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114464-114464
Closed Access | Times Cited: 88
Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications
Nikita A. Frolov, A. N. Vereshchagin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2937-2937
Open Access | Times Cited: 82
The association between toxic pesticide environmental exposure and Alzheimer’s disease: A scientometric and visualization analysis
Yanan Li, Ruying Fang, Zehua Liu, et al.
Chemosphere (2020) Vol. 263, pp. 128238-128238
Closed Access | Times Cited: 83
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease
Honghua Zhang, Yuying Wang, Yuqing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114606-114606
Closed Access | Times Cited: 55
Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies
Mariagrazia Rullo, Marco Cipolloni, Marco Catto, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3962-3977
Closed Access | Times Cited: 32
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 22
Carbamate as a potential anti‐Alzheimer's pharmacophore: A review
Yash Pal Singh, Navneet Kumar, Brijesh Singh Chauhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1624-1651
Closed Access | Times Cited: 17
Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents
Mohammed Salah Ayoup, Mohamed Reda Barakat, Hamida Abdel‐Hamid, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 2080-2097
Closed Access | Times Cited: 6
The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020
Rzgar Tawfeeq Kareem, Fahimeh Abedinifar, Evan Abdolkareem Mahmood, et al.
RSC Advances (2021) Vol. 11, Iss. 49, pp. 30781-30797
Open Access | Times Cited: 37
Promising heterocycle-based scaffolds in recent (2019–2021) anti-Alzheimer's drug design and discovery
Atukuri Dorababu
European Journal of Pharmacology (2022) Vol. 920, pp. 174847-174847
Closed Access | Times Cited: 23
Application of biomarker-derived fluorescent probes for the detection of Alzheimer's disease
Haitao Ding, Zhiqian Li, Kui Luo, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 169, pp. 117369-117369
Closed Access | Times Cited: 13
Design, synthesis, and neuroprotective activity of salidroside-based dual inhibitors of selective monoamine oxidase B and amyloid-β aggregation
Juan Zhang, Kongkai Zhu, Kaiming Wang, et al.
Medicinal Chemistry Research (2025)
Closed Access
Synthesis and in silico studies of Novel Ru(II) complexes of Schiff base derivatives of 3-[(4-amino-5-thioxo-1,2,4-triazole-3-yl)methyl]-2(3H)-benzoxazolone compounds as potent Glutathione S-transferase and Cholinesterases Inhibitor
Ragıp Adigüzel, Fikret Türkan, Ümit Yıldıko, et al.
Journal of Molecular Structure (2021) Vol. 1231, pp. 129943-129943
Closed Access | Times Cited: 25
Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties
Tomasz Wichur, Justyna Godyń, Izabella Góral, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113792-113792
Open Access | Times Cited: 24
Resveratrol-Based Carbamates as Selective Butyrylcholinesterase Inhibitors: Design, Synthesis, Computational Study and Biometal Complexation Capability
Mario Sviben, Ilijana Odak, Danijela Barić, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 316-316
Open Access
Chromone-deferiprone hybrids as novel MAO-B inhibitors and iron chelators for the treatment of Alzheimer's disease
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 30, pp. 6189-6197
Closed Access | Times Cited: 3
Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau
Tomasz Wichur, Anna Pasieka, Justyna Godyń, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113783-113783
Open Access | Times Cited: 19
Evaluation of the Key Structural Features of Various Butyrylcholinesterase Inhibitors Using Simple Molecular Descriptors
Ante Miličević, Goran Šinko
Molecules (2022) Vol. 27, Iss. 20, pp. 6894-6894
Open Access | Times Cited: 12
Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study
Martin Krátký, Quynh Anh Vu, Šárka Štěpánková, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105301-105301
Closed Access | Times Cited: 14
First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease
Rosa Purgatorio, Nicola Gambacorta, Modesto de Candia, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5208-5208
Open Access | Times Cited: 14
Palladium-Catalyzed Carbonylation of Amines with Mo(CO)6 as the Carbonyl Source
Bo Zhang, Wei Deng, Zheng‐Yang Xu
Organometallics (2023) Vol. 42, Iss. 7, pp. 588-596
Closed Access | Times Cited: 5
Design, synthesis and anticholinergic properties of novel α-benzyl dopamine, tyramine, and phenethylamine derivatives
Ali Naderi, Akın Akıncıoğlu, Ahmet Çağan, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107146-107146
Closed Access | Times Cited: 1
Design, synthesis and biological evaluation of 1-aryldonepezil analogues as anti-Alzheimer's disease agents
Jiao Luo, Jing-Jing Xu, Huijun Ren, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 10, pp. 983-997
Closed Access | Times Cited: 1
One-Pot, Three-Step Synthesis of Benzoxazinones via Use of the Bpin Group as a Masked Nucleophile
Egor M. Larin, Alexa Torelli, Joachim Loup, et al.
Organic Letters (2021) Vol. 23, Iss. 7, pp. 2720-2725
Closed Access | Times Cited: 10
Pseudo-irreversible butyrylcholinesterase inhibitors: Structure–activity relationships, computational and crystallographic study of the N-dialkyl O-arylcarbamate warhead
Anton Meden, Damijan Knez, Xavier Brazzolotto, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115048-115048
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top